Diabetes insipidus

Last updated: September 12, 2024

Diabetes insipidus

FINAL

FINAL

ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Acyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Cardiac tamponade
Endocarditis
Myocarditis
Rheumatic heart disease
Heart failure
Cor pulmonale
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Atrial flutter
Premature atrial contraction
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Deep vein thrombosis
Hypotension
Orthostatic hypotension
Polycystic kidney disease
Pheochromocytoma
Cushing syndrome
Renal artery stenosis
Hypertension
Aneurysms
Aortic dissection
Peripheral artery disease
Angina pectoris
Unstable angina
Prinzmetal angina
Myocardial infarction
Stable angina
Arterial disease
ECG normal sinus rhythm
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
ECG basics
ECG intervals
ECG axis
ECG QRS transition
ECG rate and rhythm
Cardiac conduction system
Cardiac conduction velocity
Normal heart sounds
Abnormal heart sounds
Cardiovascular changes during postural change
Cardiovascular changes during hemorrhage
Cardiac preload
Cardiac contractility
Cardiac afterload
Measuring cardiac output (Fick principle)
Thrombocytopenia: Clinical
Heparin-induced thrombocytopenia
Immune thrombocytopenia
Gout
Chronic kidney disease: Clinical
Traumatic brain injury: Pathology review
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Blood groups and transfusions
Blood products and transfusion: Clinical
HIV (AIDS)
Hodgkin lymphoma
Acromegaly
Musculoskeletal injuries: Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetes insipidus: Nursing process (ADPIE)
Managing diabetes during the holidays: Information for patients and families
Hypoglycemics: Insulin secretagogues
Insulins
Epistaxis: Nursing process (ADPIE)
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Appendicitis: Nursing process (ADPIE)
Hypothyroidism medications
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Sympathomimetics: Direct agonists
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Conjunctivitis: Nursing process (ADPIE)
Stroke: Clinical
Stroke: Nursing process (ADPIE)
Peptic ulcer
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Peptic ulcers and stomach cancer: Clinical
Gallbladder histology
Gallbladder disorders: Clinical
Acute cholecystitis
Oral cancer
Hepatitis A and Hepatitis E virus
Viral hepatitis: Clinical
Hepatitis medications
Seizures: Pathology review
Seizures: Clinical
Seizures and epilepsy
Febrile seizure
Seizure disorder: Nursing process (ADPIE)
Non-urothelial bladder cancers
Inflammatory bowel disease: Clinical
Inflammatory bowel disease: Pathology review
Anticoagulants: Heparin
Postoperative evaluation: Clinical
Trigeminal neuralgia
Trigeminal neuralgia: Nursing process (ADPIE)
Hypoparathyroidism
Pancreatitis: Pathology review
Pancreatitis: Clinical
Acute pancreatitis
Pancreatitis: Nursing process (ADPIE)
Chronic pancreatitis
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Sickle cell disease: Nursing process (ADPIE)
Class IV antiarrhythmics: Calcium channel blockers and others
Hypertension: Clinical
Pulmonary hypertension
Hypertension: Nursing process (ADPIE)
Osteoarthritis
Joint pain: Clinical
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Hyperthyroidism
Hyperthyroidism medications
Hyperthyroidism: Nursing process (ADPIE)

Transcript

Watch video only

With diabetes insipidus, “diabetes” means an increased passing of urine, and “insipidus” means tasteless; so diabetes insipidus is a condition characterized by the production of large quantities of dilute and tasteless urine.

The tasteless urine of diabetes insipidus distinguishes it from diabetes mellitus which describes sweet tasting urine- and, yes, urine was really tasted at one point in time to make that distinction!

Now, in the brain there’s a region called the hypothalamus.

Inside the hypothalamus are osmoreceptors, which can sense the osmolality of the blood, or how concentrated it is.

Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood.

There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milli Osmoles per kilogram.

During periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases.

The osmoreceptors in the hypothalamus detect the increased osmolality and that triggers the sensation of thirst, which tells us to drink more water. The water then gets absorbed and dilutes the blood, bringing the osmolality back to normal.

In addition to osmoreceptors, the hypothalamus also contains a cluster of neurons that are found in a specific spot called the supraoptic nucleus.

These neurons produce a hormone called antidiuretic hormone, or ADH. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases blood resistance and raises blood pressure.

When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH down the supraoptico-hypophyseal tract, which runs through the infundibulum or pituitary stalk, and into the posterior pituitary gland, where it is then released into the blood.

ADH travels to the kidneys, specifically to the distal convoluted tubule and collecting ducts of the nephrons and binds to a receptor called vasopressin receptor 2, or AVPR2.

When AVPR2 is bound, proteins called aquaporins, which usually sit in vesicles inside the cells of the distal convoluted tubule and collecting ducts, start to embed themselves in the apical surface of the cells, which is the side facing the lumen of the tubule.

These aquaporins ultimately allow water -- and only water -- to travel out of the lumen of the tubule and into the cells lining the nephron, and ultimately back into the blood. Just like drinking more water, this dilutes the blood, and returns plasma osmolality to a normal level.

However, this reabsorption process also decides how much water leaves the body as urine, and how concentrated the urine is, which is one of the things that keeps a normal urine osmolality between 300 and 900 milli Osmoles per kilogram.

Diabetes insipidus is when the kidneys reabsorb too little water from the lumen of the tubule, causing the body to produce unusually large quantities of urine, which is called polyuria.

Since there’s less water in the blood, plasma osmolality increases and that triggers thirst and causes an individual to drink a lot, which is called polydipsia.

There are four types of diabetes insipidus, each with its own underlying cause.

The first type is central diabetes insipidus, which is when there’s a problem in the hypothalamus or pituitary gland preventing ADH production or release. As a result, there’s insufficient ADH in the blood, and that means there is less vasoconstriction, and that there are insufficient aquaporins in the kidneys.

Central diabetes insipidus is often caused by damage to the hypothalamus osmoreceptors, the supraoptic nucleus, or the supraoptico-hypophysial tract, but in other cases, the exact cause is hard to identify.

The second type is nephrogenic diabetes insipidus, which is when there’s a problem with the kidneys themselves, which makes them unresponsive to ADH. That can happen due to a genetic defect which can lead to abnormal vasopressin receptors or aquaporin proteins that are unresponsive to ADH.

In addition, there are medications like lithium that can decrease the production of aquaporin proteins in the collecting duct.

Finally, there are kidney disorders like polycystic kidney disease that can cause diabetes insipidus.

The third type is gestational diabetes insipidus, which occurs when the placenta of a pregnant woman releases an enzyme called vasopressinase that breaks down vasopressin or ADH. As a result, ADH might still be produced and released as normal, but it doesn’t get to exert its full effect on the blood vessels or kidneys.

In women with gestational diabetes insipidus, vasopressinase is produced starting in week 8 of pregnancy, and peaks in the third trimester. As a result, the symptoms typically worsen during the course of the pregnancy right up until birth when the placenta is removed, but can continue for up to two months after birth due to residual vasopressinase.

Key Takeaways

Diabetes insipidus is when the body cannot regulate its fluid levels properly and loses a lot of water in the urine. There are two major types of diabetes insipidus, which are central and nephrogenic diabetes insipidus. Central diabetes insipidus occurs when the hypothalamus is not producing enough antidiuretic hormone (ADH). ADH ensures that the kidneys produce less urine and reduce water loss. On the other hand, nephrogenic diabetes insipidus results from the kidneys failing to respond to ADH. People with diabetes insipidus present with excessive quantities of diluted urine (polyuria), resulting in excessive thirst (polydipsia).

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "THE PATHOGENESIS OF DIABETES INSIPIDUS." Journal of the American Medical Association (1907)
  7. "Management of Hypopituitarism" Journal of Clinical Medicine (2019)
  8. "Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?" Frontiers in Endocrinology (2018)